Laxai Pharma, Ltd.

LAXAFOTCHealthcare

$0.00

+$0.00(+0.00%)

Market Cap$475341

P/E Ratio—

52W High—

52W Low—

Avg Volume2

Open$0.00

Beta2.45

Overview

Laxai Pharma, Ltd. (LAXAF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

LAXAF · earnings · updated Jun 9, 2026

Latest Earnings

Q4 FY2094Report Date: Dec 27, 1994

EPS Actual

$0.04

Est. $0.20 · -80.0%

Revenue

—

Fiscal Period

Q4 FY2094

FY ends December

Report Date

Dec 27, 1994

After Market Close

▼ Miss EPS

LAXAF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$1.00

Rev. $1.80B

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$1.00

Rev. Est.$1.80B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
▼ Q4 FY2094	Dec 27, 1994	$0.20	$0.04	-80.0%	—	—	—

Q4 FY2094

Dec 27, 1994Miss

EPS Actual

$0.04

EPS Est.

$0.20

EPS Surpr.

-80.0%

Revenue

—

No analyst estimates available for LAXAF.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▼ Q4 FY2094	Dec 27, 1994	-80.0%	No price data	$6.76	—

Q4 FY2094—

Report Date

Dec 27, 1994

EPS Beat/Miss

-80.0%

Price Before

—

Price After

$6.76

Beat Rate0 / 1 quarters

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Laxai Pharma, Ltd. (LAXAF) most recently reported earnings on December 27, 1994 for Q4 FY2094, posting EPS of $0.04 — missing the analyst consensus of $0.20 by -80.0%. The next LAXAF earnings date is expected around September 1, 2026.

Each quarter, investors track LAXAF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LAXAF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

LAXAF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

LAXAF earnings · 4 questions

Laxai Pharma, Ltd.'s next earnings report is expected around September 1, 2026. LAXAF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LAXAF historically reports after market close (AMC).

LAXAF earnings datewhen is LAXAF earningsLAXAF next earnings datewhen does LAXAF report earningsLAXAF earnings calendar

▸ Source: FMP · Laxai Pharma, Ltd. SEC filings · US GAAP · Laxai Pharma, Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026